G. Guzelant Et Al. , "EARLIER USE OF INFLIXIMAB FOR THE UVEITIS OF BEHCET'S SYNDROME APPEARS TO BE ASSOCIATED WITH BETTER OUTCOME," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.34, no.6, 2016
Guzelant, G. Et Al. 2016. EARLIER USE OF INFLIXIMAB FOR THE UVEITIS OF BEHCET'S SYNDROME APPEARS TO BE ASSOCIATED WITH BETTER OUTCOME. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.34, no.6 .
Guzelant, G., Ucar, D., Hatemi, G., Ozyazgan, Y., Esatoglu, N. S., Yurdakul, S., ... Seyahi, E.(2016). EARLIER USE OF INFLIXIMAB FOR THE UVEITIS OF BEHCET'S SYNDROME APPEARS TO BE ASSOCIATED WITH BETTER OUTCOME. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.34, no.6.
Guzelant, G. Et Al. "EARLIER USE OF INFLIXIMAB FOR THE UVEITIS OF BEHCET'S SYNDROME APPEARS TO BE ASSOCIATED WITH BETTER OUTCOME," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.34, no.6, 2016
Guzelant, G. Et Al. "EARLIER USE OF INFLIXIMAB FOR THE UVEITIS OF BEHCET'S SYNDROME APPEARS TO BE ASSOCIATED WITH BETTER OUTCOME." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.34, no.6, 2016
Guzelant, G. Et Al. (2016) . "EARLIER USE OF INFLIXIMAB FOR THE UVEITIS OF BEHCET'S SYNDROME APPEARS TO BE ASSOCIATED WITH BETTER OUTCOME." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.34, no.6.
@article{article, author={G. Guzelant Et Al. }, title={EARLIER USE OF INFLIXIMAB FOR THE UVEITIS OF BEHCET'S SYNDROME APPEARS TO BE ASSOCIATED WITH BETTER OUTCOME}, journal={CLINICAL AND EXPERIMENTAL RHEUMATOLOGY}, year=2016}